Microlearning Activities

Allies in the Race Against Time: Navigating AD with Early Detection, Therapeutic Innovations, and Patient-Centric Care

Faculty

Chuck Vega, MD

Clinical Professor of Family Medicine
University of California Irvine
Irvine, CA

James Galvin, MD, MPH

Professor of Neurology
 Chief, Division of Cognitive Neurology
Director, Comprehensive Center for Brain Health Director, Lewy Body Dementia Research Center of Excellence


Carol O'Dell

Speaker and Caregiver Wellness Blogger
Fernandina Beach, FL

Program Overview

Alzheimer's disease (AD) is a progressive and devastating neurodegenerative disorder that affects a significant portion of the elderly population and is increasing globally. Recent advancements in disease-modifying therapies have brought hope for slowing or preventing disease progression and improving patient outcomes. However, timely diagnosis and early intervention are crucial for maximizing the likelihood of successful treatment. Clinicians, families, and researchers need to be aware of the importance of early recognition and diagnosis of AD, as well as the latest evidence on biomarkers that aid in early diagnosis. Additionally, understanding the mechanisms of action, efficacy, and safety data for new and emerging disease-modifying therapies is essential. 

Target Audience

The educational design of this activity addresses the needs of healthcare professionals who provide care for patients primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants.
This activity is jointly provided by Global Education Group and Iridium Continuing Education.
SUPPORTER ACKNOWLEDGEMENT
This activity is supported by an independent educational grant from
Eisai, Inc.